Determining the Severity of Atopic Dermatitis in Children Presenting in General Practice: An Easy and Fast Method | Zendy

Marjolein G. Willemsen | Zendy; Rosalinda W. C. van Valburg | Zendy; P. C. Dirven-Meijer | Zendy; Arnold P. Oranje | Zendy; Johannes C. van der Wouden | Zendy; H. D. Moed | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Determining the Severity of Atopic Dermatitis in Children Presenting in General Practice: An Easy and Fast Method

Author(s) -

Marjolein G. Willemsen,

Rosalinda W. C. van Valburg,

P. C. Dirven-Meijer,

Arnold P. Oranje,

Johannes C. van der Wouden,

H. D. Moed

Publication year - 2009

Publication title -

dermatology research and practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.456

H-Index - 29

eISSN - 1687-6113

pISSN - 1687-6105

DOI - 10.1155/2009/357046

Subject(s) - scorad , medicine , atopic dermatitis , kappa , correlation , severity of illness , clinical practice , dermatology , disease , physical therapy , mathematics , geometry , dermatology life quality index

Assessment of the severity of atopic dermatitis (AD) is necessary to evaluate the disease process. This study evaluates and validates the TIS in children with AD presenting in general practice. Independent investigators determined the severity of AD using the TIS and the objective SCORAD. The interobserver agreement for the TIS and SCORAD was calculated, as was the correlation between TIS and SCORAD. The mean time to assess the TIS was less than one minute. A moderate-to-good agreement between the observers was found for the TIS ( κ = 0.604 or 0.464), or SCORAD ( κ = 0.695 or 0.700). There was an excellent correlation between TIS and SCORAD ( r s = 0.755–0.839). In conclusion, the TIS is an easy and fast method to score AD. Because of the moderate to good interobserver agreement and the high correlation with the SCORAD, we recommend the TIS to determine the severity of AD in general practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research